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Clinical procedures for patient positioning are designed 
to minimize systematic errors in the treatment geometry. 
However, despite the use of advanced technologies, ana-
tomical variations and practical issues limit the accuracy 
of daily setup. In addition, the estimation of stopping 
power for different tissues from CT data has intrinsic un-
certainties. 
In order to quantify the degradation of dose distribution 
due to such residual uncertainties, we have retrospectively 
tested the robustness of intensity modulated carbon ion 
plans for the treatment of clivus chordoma. 
Materials and Methods 
Ten patients treated at the Centro Nazionale di Adroter-
apia Oncologica (IT) were selected for this study. The 
treatment consisted of 16 fractions, 4.4 Gy (RBE) each. In 
our study we considered the enlarged PTV applied in the 
first 10 fractions before boosting the treatment to a small-
er volume. The PTV was obtained by applying 2 mm ex-
pansion from the CTV. The brainstem was included as 
organ at risk, with a maximum 30% of the fraction dose.  
We derived the setup errors from the clinical practice at 
the institution [1] featuring six degrees of freedom couch 
and 2D-3D image registration software. We have identi-
fied the ±1.0 mm and ±1.0° ranges to cover the 95% of 
observed residual setup errors. Orthogonal sampling was 
applied on the error space, thus defining 64 trials to ex-
plore the effects of setup errors in a statistically equiva-
lent dataset. Accordingly, the patients’ planning CTs were 
rigidly transformed and considered for dose recalculation. 
Treatment planning was based on TRiP98 and LEM-I 
(α/β = 2) using 6 mm beam FWHM with 2 mm by 3 mm 
raster grid in lateral and depth dimensions.  
We have evaluated DVH bands at 95% (D95CTV) and 
105% (D105CTV) dose for CTV and 5% (D05OAR) for the 
brainstem. In addition, inhomogeneity (IC) and conformi-
ty (CI) indexes were calculated for the CTV.  
Setup error cases resulting in larger variation on the 
target DVH were considered for the analysis of stopping 
power uncertainties. Only the worst-case scenario report-
ed by Rietzel et al. [2] for head&neck tissues was consid-
ered, thus applying ±2.6% deviations from nominal val-
ues.  
Results  
On 7 patients out of 10, the D95CTV error was always 
below 10% in presence of setup errors. Instead, larger 
discrepancies were observed in combination with range 
uncertainties, whereas their effect on the organ at risk is 
related to the specific patient anatomy (Figure 1).  
The CICTV exhibited reduced sensitivity to setup errors 
with respect to the ICCTV. Conversely, range uncertainties 
affected significantly the CICTV, but minor variations were 
reported for ICCTV. Higher values for ICCTV in nominal 
conditions were reported to be prone to large deviation 
when uncertainties occur. Finally, a strong correlation (ρ 
= 0.91) was found between the nominal treatment plan 
ICCTV and its score in presence of setup errors. 
Figure 1: axial dose cut in nominal geometry (left panel), in 
presence of setup errors (top-right panel) and combination of 
setup and HU-WE uncertainties (bottom-right panel). 
Conclusions and outlook 
We have recalculated the patient dose in presence of 
setup and range errors to test the treatment plan robust-
ness. Even though conformity is generally preserved, the 
combination of setup and range errors has an impact on 
the treatment quality. On this basis, we have further in-
vestigated the role of fractionation to mitigate the patient 
dose degradation [3].  
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